Ilya Petrou, M.D.
The successful aesthetic consult
Kent Remington, M.D., guides patients through his method for conducting a successful aesthetic consult, he told attendees at the MauiDerm 2014 meeting. Knowing a patient’s “real” reasons for aesthetic improvement — and shifting from a monotherapy toward performing a full-face rejuvenation following a multitherapeutic approach — are essential in achieving excellent aesthetic outcomes, he told attendees at the MauiDerm 2014 meeting.
Initial accurate diagnosis critical for rare tumors
Atypical fibroxanthoma (AFX) and undifferentiated pleomorphic sarcoma (UPS) share a similar histological picture. But unlike AFX, UPS can have an aggressive clinical course, underscoring the importance of initial accurate diagnosis of these tumors, and the implementation of appropriate therapy.
SCC staging update defines high-risk tumors
A new tumor staging system for cutaneous squamous cell carcinoma (CSCC) has recently been put forward that, according to one recent study, improves prognostic discrimination by more precisely defining the small subset of tumors with a high risk of metastatic and death.
Next generation technologies promise to enhance treatment of disease
The implementation of next generation technologies coupled with the acquisition of a more in-depth knowledge of dermatologic diseases and conditions are proving to be very helpful in better treating and managing patients.
Secukinumab shows superiority to etanercept
Secukinumab shows superiority to etanercept
Recent head-to-head clinical trial results with secukinumab (Novartis) and etanercept (Enbrel, Amgen) show a significant superiority of secukinumab in the treatment and management of patients with moderate-to-severe plaque psoriasis, perhaps heralding a new standard of care for this patient population.
Vismodegib effective for treating challenging basal cell carcinomas
Vismodegib (Erivedge, Genentech) is demonstrating effectiveness for the treatment of metastatic and locally advanced basal cell carcinoma (BCC), offering hope for patients with this notoriously challenging disease.
New modalities revolutionize chronic wound management
New therapeutic modalities such as bioactive extracellular matrices, laser therapy and others have revolutionized the treatment and management of chronic wounds, allowing clinicians to achieve much faster wound closures in their patients.
Apps make delivery of medicine more personal
Smartphone applications (apps) have become very popular in mainstream medicine and dermatology. Though the use of apps can and should not replace clinical judgment or physician interaction, smartphone apps can be practical and helpful in facilitating dermatologic care on both sides of the physician-patient spectrum.
Quality time with patients improves adherence to medications
Patient compliance to suggested therapy, whether topic or oral, remains the major obstacle in achieving good treatment outcomes in dermatology. Establishing trust with the patient, choosing a treatment plan that the patient likes, and scheduling the follow-up visit soon after first presentation are all key steps the physician can take in helping to improve patient compliance and further, treatment outcomes.
Early detection, treatment critical for oral lesions
Cancers and precancers of the oral mucosa are notoriously challenging to treat and, according to one expert, a heightened vigilance spanning different specialties remains key in reducing the morbidity and mortality in patients.

Poll

View Results